Keywords: eli, lilly, presents, positive, data, asco, marking

Eli Lilly presents positive data at ASCO marking a new phase of innovation

Article | 30 May 2005

Print This

According to Richard Gaynor, vice president of cancer research and clinical investigation at US drugmaker Eli Lilly, "there have been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in